The electrocompetent cells market is estimated to be valued at US$ 2.07 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030. Electrocompetent cells facilitate efficient DNA uptake and expression in various recombinant protein production, gene cloning, gene expression, genomics, and proteomics applications. The demand for electrocompetent cells is increasing owing to rising R&D spending on genomics and growth in the field of life sciences research. Key players operating in the electrocompetent cells market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), and SelectScience, Biosearch Technology.
Key Takeaways
Key players operating in the electrocompetent cells market are focusing on new product launches to expand their product portfolios. For instance, in 2022 Lucigen Corporation launched Lucigen E. cloni 10G ELITE Electrocompetent Cells with higher transformation efficiencies.
The demand for electrocompetent cells is increasing owing to expanding applications of genomics in precision medicine and agriculture. Growth in genomics start-ups is also fueling market growth.
Technological advancements such as new plasmid designs and automated electroporation protocols are improving transformation efficiencies of electrocompetent cells. AI-powered algorithms are also being used for optimizing transformation protocols.
Market Trends
1. Increase in outsourcing of recombinant DNA services: Growing reliance of pharma and biotech companies on contract development and manufacturing organizations (CDMOs) for recombinant protein production is driving demand for electrocompetent cells.
2. Adoption of CRISPR gene editing: The increasing adoption of CRISPR gene editing technique for applications in genetic engineering and genome editing has fueled the need for highly efficient electrocompetent cells.
Market Opportunities
1. Expanding genomics applications in precision medicine: Growth in the field of precision medicine and the move towards personalized healthcare is expected to boost the applications of genomics and drive demand for electrocompetent cells.
2. Agricultural biotechnology applications: Use of genome editing techniques such as CRISPR for developing traits in crops has potential to drive opportunities in the electrocompetent cells market for agricultural applications.
Impact of COVID-19 on Electrocompetent Cells Market Growth
The COVID-19 pandemic has significantly impacted the growth of the electrocompetent cells market. During the initial phase of the pandemic, production and supply chain disruptions adversely affected the market. Travel restrictions imposed worldwide led to delays in research and development activities by pharma and biotech companies. This subsequently reduced the demand for electrocompetent cells which are extensively used in DNA cloning, genetic engineering and protein production. However, with more focus on vaccine and therapeutic development for COVID-19 treatment, the demand for these cells started reviving in 2021. Various institutions and companies ramped up their research to find solutions to fight the pandemic. This stimulated the electrocompetent cells market and attenuated the negative impacts of COVID-19 to some extent. Going forward, the post-COVID scenario is expected to further drive the market growth owing to increased R&D investments, streamlined production & robust supply chains. Continued emphasis on infectious disease prevention and preparedness will also support the long term prospects of this market.
The United States currently accounts for the largest share of the global electrocompetent cells market in terms of value. This is due to heavy investments in biomedical research by both private and public sectors in the country. Presence of top pharmaceutical companies and availability of state-of-the-art research infrastructure also contributes to the dominant position of the US market. However, China is emerging as the fastest growing regional market for electrocompetent cells. Expanding biotech industry, increasing biomedical grants & favorable government policies are fueling the market growth in China. Rising biologics production in China is another key factor propelling the demand for electrocompetent cells in the country. With thriving biosimilars industry, China is likely to take over the top spot globally in the coming years.
A new business intelligence report released by AMA Research with title "Electrocompetent Cells Market Insights, Forecast to 2026" provides latest updates and strategic steps taken by competition along with growth estimates of market size.
If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization according to your requirement.
This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts, understanding current investments cycle and impact of COVID-19 and slowdown.
The report presents the market competitive landscape and in depth analysis of the major vendor/key players in the market along with their strategies to overcome production cycle issue and supply chain management to make process efficient.
The Electrocompetent Cells Market segments and Market Data Break Down are illuminated below: by Type (Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells), Application (Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)), Phases (Lag Phase, Log Phase, Stationary Phase, Death Phase), End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations (CROs)) Furthermore, the years considered for the study are as follows: Historical year – 2015-2020 Base year – 2020 Forecast period** – 2021 to 2026 [** unless otherwise stated] **Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
